n CME : Your SA Journal of CPD - Pre-diabetes and the metabolic syndrome : more about... chemical pathology
|Article Title||Pre-diabetes and the metabolic syndrome : more about... chemical pathology|
|© Publisher:||Health and Medical Publishing Group (HMPG)|
|Journal||CME : Your SA Journal of CPD|
|Affiliations||1 University of KwaZulu-Natal|
|Publication Date||Jul 2012|
|Pages||252 - 253|
The American Diabetes Association (ADA) defines pre-diabetes as a fasting plasma glucose (FPG) ≥5.6 mmol/l but <7.0 mmol/l, which is termed impaired fasting glycaemia (IFG), or an abnormal 2-hour response to a 75 g oral glucose tolerance test (OGTT) of at least 7.8 mmol/l and <11.1 mmol/l, which is termed impaired glucose tolerance (IGT), or an HbA1c of 5.7 - 6.4%. It is used to identify individuals with a greater risk of developing overt type 2 diabetes and also those at increased cardiovascular risk. Pre-diabetes represents a continuum in the spectrum between normoglycaemia and overt hyperglycaemia.
Article metrics loading...